HESX1: Difference between revisions
Jump to navigation
Jump to search
m (Bot: HTTP→HTTPS) |
imported>Nemo bis (Added free to read link in citations with OAbot #oabot) |
||
| Line 17: | Line 17: | ||
*{{cite journal |vauthors=Torrado M, Revuelta J, Gonzalez C, etal |title=Role of conserved salt bridges in homeodomain stability and DNA binding |journal=J. Biol. Chem. |volume=284 |issue= 35 |pages= 23765–79 |year= 2009 |pmid= 19561080 |doi= 10.1074/jbc.M109.012054 |pmc=2749150 }} | *{{cite journal |vauthors=Torrado M, Revuelta J, Gonzalez C, etal |title=Role of conserved salt bridges in homeodomain stability and DNA binding |journal=J. Biol. Chem. |volume=284 |issue= 35 |pages= 23765–79 |year= 2009 |pmid= 19561080 |doi= 10.1074/jbc.M109.012054 |pmc=2749150 }} | ||
*{{cite journal |vauthors=Dattani MT, Robinson IC |title=HESX1 and Septo-Optic Dysplasia |journal=Rev Endocr Metab Disord |volume=3 |issue= 4 |pages= 289–300 |year= 2002 |pmid= 12424431 |doi= }} | *{{cite journal |vauthors=Dattani MT, Robinson IC |title=HESX1 and Septo-Optic Dysplasia |journal=Rev Endocr Metab Disord |volume=3 |issue= 4 |pages= 289–300 |year= 2002 |pmid= 12424431 |doi= }} | ||
*{{cite journal |vauthors=Carvalho LR, Woods KS, Mendonca BB, etal |title=A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction |journal=J. Clin. Invest. |volume=112 |issue= 8 |pages= 1192–201 |year= 2003 |pmid= 14561704 |doi= 10.1172/JCI18589 |pmc=213489 }} | *{{cite journal |vauthors=Carvalho LR, Woods KS, Mendonca BB, etal |title=A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction |journal=J. Clin. Invest. |volume=112 |issue= 8 |pages= 1192–201 |year= 2003 |pmid= 14561704 |doi= 10.1172/JCI18589 |pmc=213489 |url=http://discovery.ucl.ac.uk/8411/1/8411.pdf }} | ||
*{{cite journal |vauthors=Diaczok D, Romero C, Zunich J, etal |title=A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency |journal=J. Clin. Endocrinol. Metab. |volume=93 |issue= 11 |pages= 4351–9 |year= 2008 |pmid= 18728160 |doi= 10.1210/jc.2008-1189 |pmc=2582563 }} | *{{cite journal |vauthors=Diaczok D, Romero C, Zunich J, etal |title=A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency |journal=J. Clin. Endocrinol. Metab. |volume=93 |issue= 11 |pages= 4351–9 |year= 2008 |pmid= 18728160 |doi= 10.1210/jc.2008-1189 |pmc=2582563 }} | ||
*{{cite journal |vauthors=Fintini D, Salvatori R, Salemi S, etal |title=Autosomal-dominant isolated growth hormone deficiency (IGHD type II) with normal GH-1 gene |journal=Horm. Res. |volume=65 |issue= 2 |pages= 76–82 |year= 2006 |pmid= 16424673 |doi= 10.1159/000091033 }} | *{{cite journal |vauthors=Fintini D, Salvatori R, Salemi S, etal |title=Autosomal-dominant isolated growth hormone deficiency (IGHD type II) with normal GH-1 gene |journal=Horm. Res. |volume=65 |issue= 2 |pages= 76–82 |year= 2006 |pmid= 16424673 |doi= 10.1159/000091033 }} | ||
Latest revision as of 16:04, 4 November 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
Homeobox expressed in ES cells 1, also known as homeobox protein ANF, is a homeobox protein that in humans is encoded by the HESX1 gene.[1]
Expression of HEX1 and HESX1 marks the anterior visceral endoderm of the embryo. The AVE is an extra-embryonic tissue, key to the establishment of the anterior-posterior body axis.
Clinical significance
Mutations in the HESX1 gene are associated with some cases of septo-optic dysplasia[2] or Pickardt-Fahlbusch syndrome.[3]
References
- ↑ "Entrez Gene: HESX homeobox 1".
- ↑ Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. (1998). "Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse". Nat. Genet. 19 (2): 125–33. doi:10.1038/477. PMID 9620767.
- ↑ Reynaud R, Albarel F, Saveanu A, Kaffel N, Castinetti F, Lecomte P, Brauner R, Simonin G, Gaudart J, Carmona E, Enjalbert A, Barlier A, Brue T (January 2011). "Pituitary Stalk Interruption Syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms". Eur J Endocrinol. 164 (4): 457–65. doi:10.1530/EJE-10-0892. PMID 21270112.
Further reading
- Carvalho LR, Brinkmeier ML, Castinetti F, et al. (2010). "Corepressors TLE1 and TLE3 interact with HESX1 and PROP1". Mol. Endocrinol. 24 (4): 754–65. doi:10.1210/me.2008-0359. PMC 2852357. PMID 20181723.
- Kim SS, Kim Y, Shin YL, et al. (2003). "Clinical characteristics and molecular analysis of PIT1, PROP1,LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging". Horm. Res. 60 (6): 277–83. doi:10.1159/000074245. PMID 14646405.
- Torrado M, Revuelta J, Gonzalez C, et al. (2009). "Role of conserved salt bridges in homeodomain stability and DNA binding". J. Biol. Chem. 284 (35): 23765–79. doi:10.1074/jbc.M109.012054. PMC 2749150. PMID 19561080.
- Dattani MT, Robinson IC (2002). "HESX1 and Septo-Optic Dysplasia". Rev Endocr Metab Disord. 3 (4): 289–300. PMID 12424431.
- Carvalho LR, Woods KS, Mendonca BB, et al. (2003). "A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction" (PDF). J. Clin. Invest. 112 (8): 1192–201. doi:10.1172/JCI18589. PMC 213489. PMID 14561704.
- Diaczok D, Romero C, Zunich J, et al. (2008). "A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency". J. Clin. Endocrinol. Metab. 93 (11): 4351–9. doi:10.1210/jc.2008-1189. PMC 2582563. PMID 18728160.
- Fintini D, Salvatori R, Salemi S, et al. (2006). "Autosomal-dominant isolated growth hormone deficiency (IGHD type II) with normal GH-1 gene". Horm. Res. 65 (2): 76–82. doi:10.1159/000091033. PMID 16424673.
- Dateki S, Fukami M, Uematsu A, et al. (2010). "Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion". J. Clin. Endocrinol. Metab. 95 (8): 4043–7. doi:10.1210/jc.2010-0150. PMID 20534763.
- Cohen RN, Cohen LE, Botero D, et al. (2003). "Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia". J. Clin. Endocrinol. Metab. 88 (10): 4832–9. doi:10.1210/jc.2002-021868. PMID 14557462.
- Sobrier ML, Maghnie M, Vié-Luton MP, et al. (2006). "Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities". J. Clin. Endocrinol. Metab. 91 (11): 4528–36. doi:10.1210/jc.2006-0426. PMID 16940453.
- Dasen JS, Rosenfeld MG (2001). "Signaling and transcriptional mechanisms in pituitary development". Annu. Rev. Neurosci. 24: 327–55. doi:10.1146/annurev.neuro.24.1.327. PMID 11283314.
- Tajima T, Hattorri T, Nakajima T, et al. (2003). "Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient". J. Clin. Endocrinol. Metab. 88 (1): 45–50. doi:10.1210/jc.2002-020818. PMID 12519827.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Mellado C, Poduri A, Gleason D, et al. (2010). "Candidate gene sequencing of LHX2, HESX1, and SOX2 in a large schizencephaly cohort". Am. J. Med. Genet. A. 152A (11): 2736–42. doi:10.1002/ajmg.a.33684. PMC 2965295. PMID 20949537.
- Sajedi E, Gaston-Massuet C, Andoniadou CL, et al. (2008). "DNMT1 interacts with the developmental transcriptional repressor HESX1". Biochim. Biophys. Acta. 1783 (1): 131–43. doi:10.1016/j.bbamcr.2007.08.010. PMC 2233781. PMID 17931718.
- McNay DE, Turton JP, Kelberman D, et al. (2007). "HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism". J. Clin. Endocrinol. Metab. 92 (2): 691–7. doi:10.1210/jc.2006-1609. PMID 17148560.
- Kelberman D, Dattani MT (2007). "Genetics of septo-optic dysplasia". Pituitary. 10 (4): 393–407. doi:10.1007/s11102-007-0055-5. PMID 17587179.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ravasi T, Suzuki H, Cannistraci CV, et al. (2010). "An atlas of combinatorial transcriptional regulation in mouse and man". Cell. 140 (5): 744–52. doi:10.1016/j.cell.2010.01.044. PMC 2836267. PMID 20211142.
- Dattani MT (2003). "Borjeson-Forssman-Lehmann syndrome: a novel pituitary phenotype due to mutation in a novel gene". J. Pediatr. Endocrinol. Metab. 16 (9): 1207–9. doi:10.1515/jpem.2003.16.9.1207. PMID 14714741.
External links
- GeneReviews/NCBI/NIH/UW entry on Anophthalmia / Microphthalmia Overview
- HESX1+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
 | This article on a gene on human chromosome 3 is a stub. You can help Wikipedia by expanding it. |